Frank L. Jaksch Jr.

All filings by Frank L. Jaksch Jr. on record concern Niagen Bioscience, Inc. We count 8 filings; the first trade dates from 29 March 2018 and the latest from 13 December 2024.

Both buying and selling appear: 1 purchase worth €11k, against 3 sales worth €209k. The net balance comes to €198k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 option exercises.

The latest filing, published on 13 December 2024, reports an option exercise of €175k in Niagen Bioscience, Inc. The most recent open-market purchase was published on 13 June 2023, 1,229 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.